http://www.unboundmedicine.com/medline/ebm/research/zoledronic_acidUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19041433/full_citation/Inhibition_of_bone_resorption_and_growth_of_breast_cancer_in_the_bone_microenvironment_Buijs JT, Que I, Löwik CW, et al. 
Inhibition of bone resorption and growth of breast cancer in the bone microenvironment. [JOURNAL ARTICLE]
Bone 2008 Nov 8.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19040323/full_citation/Unilateral_anterior_uveitis_complicating_zoledronic_Acid_therapy_in_prostate_cancer_Banal F, Briot K, Ayoub G, et al. 
Unilateral anterior uveitis complicating zoledronic Acid therapy in prostate cancer. [Letter]
J Rheumatol 2008 Dec; 35(12):2458-9.
Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19038763/full_citation/Pharmacovigilance_and_reporting_oversight_in_US_FDA_fast_track_process:_bisphosphonates_and_osteonecrosis_of_the_jaw_Edwards BJ, Gounder M, McKoy JM, et al. 
Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jaw. [Journal Article]
Lancet Oncol 2008 Dec; 9(12):1166-72.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19036117/full_citation/Effect_of_zoledronic_acid_on_oral_fibroblasts_and_epithelial_cells:_a_potential_mechanism_of_bisphosphonate_associated_osteonecrosis_Scheper MA, Badros A, Chaisuparat R, et al. 
Effect of zoledronic acid on oral fibroblasts and epithelial cells: a potential mechanism of bisphosphonate-associated osteonecrosis. [JOURNAL ARTICLE]
Br J Haematol 2008 Nov 20.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19028356/full_citation/Osteoporosis_and_osteoporotic_fracture_occurrence_and_prevention_in_the_elderly:_a_geriatric_perspective_Boonen S, Dejaeger E, Vanderschueren D, et al. 
Osteoporosis and osteoporotic fracture occurrence and prevention in the elderly: a geriatric perspective. [Journal Article]
Best Pract Res Clin Endocrinol Metab 2008 Oct; 22(5):765-85.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19018458/full_citation/Zoledronic_acid_in_treatment_of_bone_lesions_by_Langerhans_cell_histiocytosis_Montella L, Merola C, Merola G, et al. 
Zoledronic acid in treatment of bone lesions by Langerhans cell histiocytosis. [JOURNAL ARTICLE]
J Bone Miner Metab 2008 Nov 19.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19016713/full_citation/Peripheral_blood_monocytes_are_responsible_for_gammadelta_T_cell_activation_induced_by_zoledronic_acid_through_accumulation_of_IPP/DMAPP_Roelofs AJ, Jauhiainen M, Mönkkönen H, et al. 
Peripheral blood monocytes are responsible for gammadelta T cell activation induced by zoledronic acid through accumulation of IPP/DMAPP. [JOURNAL ARTICLE]
Br J Haematol 2008 Nov 7.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19014338/full_citation/Change_in_Markers_of_Bone_Metabolism_with_Chemotherapy_for_Advanced_Prostate_Cancer:_Interleukin_6_Response_Is_a_Potential_Early_Indicator_of_Response_to_Therapy_Woods Ignatoski KM, Friedman J, Escara-Wilke J, et al. 
Change in Markers of Bone Metabolism with Chemotherapy for Advanced Prostate Cancer: Interleukin-6 Response Is a Potential Early Indicator of Response to Therapy. [JOURNAL ARTICLE]
J Interferon Cytokine Res 2008 Nov 17.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19006441/full_citation/Analysis_of_costs_associated_with_administration_of_intravenous_single_drug_therapies_in_metastatic_breast_cancer_in_a_u_s__Population_Kruse GB, Amonkar MM, Smith G, et al. 
Analysis of costs associated with administration of intravenous single-drug therapies in metastatic breast cancer in a u.s. Population. [Journal Article]
J Manag Care Pharm 2008 Nov-Dec; 14(9):844-57.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/18990168/full_citation/Systemic_therapy_for_advancing_or_metastatic_prostate_cancer__STAMPEDE_:_a_multi_arm_multistage_randomized_controlled_trial_James ND, Sydes MR, Clarke NW, et al. 
Systemic therapy for advancing or metastatic prostate cancer (STAMPEDE): a multi-arm, multistage randomized controlled trial. [JOURNAL ARTICLE]
BJU Int 2008 Oct 8.
Abstract | Full Citation